chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Congestion Runny nose Fatigue; Congestion Runny nose Fatigue; Congestion Runny nose Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion Runny nose Fatigue), RHINORRHOEA (Congestion Runny nose Fatigue) and FATIGUE (Congestion Runny nose Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 057MZ1A, 071FZ1A, 044BZ1A and 007BZ1A) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment.    Previously administered products included for Drug use for unknown indication: Pencillin. Past adverse reactions to the above products included Allergy with Pencillin. Concurrent medical conditions included Cardiovascular disease, unspecified.   On 24-Mar-2021 at 7:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021 at 8:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021 at 4:30 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2022 at 2:15 PM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 17-May-2022 at 1:00 PM, the patient experienced NASAL CONGESTION (Congestion Runny nose Fatigue), RHINORRHOEA (Congestion Runny nose Fatigue) and FATIGUE (Congestion Runny nose Fatigue). At the time of the report, NASAL CONGESTION (Congestion Runny nose Fatigue), RHINORRHOEA (Congestion Runny nose Fatigue) and FATIGUE (Congestion Runny nose Fatigue) had not resolved. Not Provided          The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously received a COVID-19 Vaccine.  The patient was not hospitalized and not received treatment.
Swelling, redness, feels warm to touch at the injection site early sign of cellulitis. Treated with dicloxacillin 250 mg by Dr.
type 2 diabetes; This spontaneous report has been received from a medical assistant referring to a currently 65 years old female patient. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were unknown by the reporter.      On 29-APR-2002, the patient was vaccinated with a dose of pneumococcal polysaccharide vaccine (manufacturer unknown) (strength, dose, frequency, route, lot number and expiration date were not reported) for prophylaxis.         On an unknown date, the patient was diagnosed with type 2 diabetes.  It is unclear if the event occurred prior to or after the patient was vaccinated with the pneumococcal polysaccharide vaccine (manufacturer unknown). It was unknown if the patient received treatments. The outcome of type 2 diabetes was unknown.    The causality between the event and pneumococcal polysaccharide vaccine (manufacturer unknown) was not provided.  Upon internal review, the event type 2 diabetes was determined to be medically significant.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 71-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 22-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250802, expiry date: 30-Jun-2019 and dose: not reported] which underwent temperature excursion. On 22-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: left deltoid, batch number; 250802, expiry date: 30-Jun-2019 and dose: not reported] which underwent temperature excursion. The reported batch number (250802), does not match FLUCELVAX batch numbers, however, the batch number was mapped to FLUAD (TIV). Hence, the suspect vaccine was coded as FLUAD (TIV). At the time of this report, no adverse event was reported. This case 201805438 was crossed linked to original case 201804863 due to same reporter.
after recv vax pt exp generalized rash beginning @ approx 8pm 5/6.  pt seen by m.d. 5/7, given meds.
3 days of fever, headache, body aches On day 4 of headache Diarrhea on day 4 after vaccine On day 4 of blurred vision in right eye as well as muscle pain behind the right eye
while mom & pt waiting in waiting room, pt face started to break out;immun given 12:30 broke out 12:40;hives to rt side of face by ear, hives to lt eyebrow & forehead; 2 hives under lt eye;red bumps;
Fever, chills, runny nose, cough, sneeze 6 days after vaccine received.
Patient was standing up after vaccination and then turned pale, mom caught patient before she fell and put her up on patient bed feet elevated. BP is 122/90 at 3:27pm. Patient is conscious, Mom states symptoms never occurred in previous vaccinations. Patient advised to lie down a couple of minutes.
Site: Pain at Injection Site-Mild, Systemic: Blood Disorder  (diagnosed by MD)-Severe, Systemic: dvt-Severe, Additional Details: pt diagnosed with dvt blood clot in right leg 2 days after vaccine.
Approx 3 hours after getting vaccine began getting stomach cramps, felt nauseous, had some diarrhea, vomited once small amount, myalgias, malaise. Wife who is medical assistant reported this next day on 2/21 at 2:00 PM . Advised to go to medical provider/urgent care if they are concerned with his symptoms or believe symptoms are worsening so medical provider can assess whether symptoms are adverse vaccine reaction or perhaps coincidental unrelated illness.
she felt a little tightness in her chest; This is a spontaneous report from the Pfizer sponsored program. A contactable consumer (Patient) reported that a female patient of an unspecified age received a second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 23Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously had an BNT162b2 (First dose) for COVID-19 immunization on 05Mar2021. Patient stated that she had her second shot of the vaccine yesterday (23Mar2021). She said it seems okay, but she felt a little tightness in her chest. She called in to ask if it is normal. Outcome of the event was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
This spontaneous report was received from a medical assistant regarding a patient of unknown demographics. There was no information about concurrent condition and historical medication. On 28-NOV-2016 the patient was vaccinated with improperly stored PNEUMOVAX 23 lot # M042599/ expiration date-17-JUN-2018, for prophylaxis (incorrect product storage). No adverse event was reported. The outcome of the event was unknown. Temperature and time frame was 77 F for 6 hours. Call was not because of a data logger and there was no previous temperature excursion. No PQC (product quality complaint) was involved. Additional information has been requested.
Expired vaccine was administered to this patient. Vaccine expired 07/31/2020 vaccine was given today 8/4/2020 Ma noticed after she had administered vaccine when she was documenting.  No symptom or signs of a adverse event after the vaccine.
Patient reported heart pounding and like someone was twisting her chest. She had a high blood pressure and pulse about 15 minutes after getting shot
Intussusception.  8/21/2007 Vax record received and reviewed.  Initial hospital record also rec'd. Infant presented for c/o 1 week hx of intermittent vomiting and abdominal pain.  Initially seen 7/13 & 7/14 for same.  DXd with viral illness/gastroenteritis. Admitted for further w/u.  PE (+) for hypoactive BS, tenderness to palpation.  BE (+) for IS.  Unable to reduce x3.  Transfered to another facility for surgical reduction of intussusception.
PATIENT CONTACTED ME 7/21 NOTING REDNESS, SWELLING, INFLAMMATION AT THE SITE OF THE INJECTION AND THE SURROUNDING AREA.
Right after the injection, I had minor arm soreness which increased as the day went on. Approximately 12 hours after the injection I started feeling very tired and achy. My arm hurt very badly and I started getting chills. About an hour later I had a 101.1 degree fever. I also experienced very slight shortness of breath which went away when I used my albuterol inhaler. My shoulder where I got the injection hurt so badly that I could like raise it, lie on it or touch it really.   The fever continued into the night but was gone by around 9am.   I continued to feel tired and achy all day the next day, with occasional shooting headache pains. I did feel better and better as the day went on though.   Question: I take a daily supplement of 6g of marine collagen. I happened to take the marine collagen 1 hour before the onset of chills and fever - could there be a correlation between the collagen and the worsening symptoms? I have never had any type of reaction to the collagen before and have been taking it for about 3 weeks.
high blood pressure; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (high blood pressure). At the time of the report, HYPERTENSION (high blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   Treatment information not provided.
This spontaneous report was received from a currently 75 year old female patient, reporting on herself. The patient did not have pertinent medical history, drug reactions or allergies. On an unknown date, the patient was vaccinated with ZOSTAVAX (dosage information, lot number and expiration date were not informed), single 0.65 mL, subcutaneously, for prevention of shingles. Concomitant medication included unspecified diabetic medication, unspecified cholesterol and high blood pressure medication. On an unknown date the patient, reported pain in her back and a "red, bumby rash" on right arm from elbow to hand. The patient also reported "tingly feeling" in right hand. On an unknown date, she was diagnosed with shingles, after receiving  ZOSTAVAX. It was also informed that the patient received an unspecified treatment for the adverse events. And she sought medical attention at an office visit. At the time of reporting, the outcome of herpes zoster and back pain was reported as not recovered. The causality assessment between herpes zoster and back pain and therapy with ZOSTAVAX was not provided. Additional information has been requested.
Moderna expired on 01/22/22 and was administered to the patient on Mon. 01/24/22.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna expired on 01/22/22 and was administered to the patient on Mon. 01/24/22.) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2022 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna expired on 01/22/22 and was administered to the patient on Mon. 01/24/22.). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Moderna expired on 01/22/22 and was administered to the patient on Mon. 01/24/22.) had resolved. Not applicable      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications and no treatment medications were reported.
Received the vaccine on 04/01/2022 and on 05/07/2022 in the afternoon  i had a sore throat. Two days later i began to get sicker. i had severe headache eye pain chest tightness sinus infection and low grade fever . went to check and was positive for covid.
Heavy period leading to Iron Deficiency Anemia; First period starting 1 day before vaccine and heavy bleeding started 1 day following vaccine. Bleeding last 14 days. Second period started April 16 and lasted 15+ days  Weight loss of approximately 20lbs in the following 6 weeks
Within 6 hours of administration, pt had severe flu-like symptoms - subjective fever/chills, aches, weakness, dizziness. These symptoms resolved on their on within 48 hours. Pt took acetaminophen per instructions and diphenhydramine . Pt also complained of dry, red, itchy eyes 24 hours after onset of symptoms for which more diphenhydramine was taken.
12/05/21 PM:  injection site pain, severe headache, fever 101.4,  arm pain & feeling unwell overall 12/06/21 AM & PM:  chills, tiredness, muscle pain, joint pain, fever 100.1 / 99.4, diarrhea, arm pain & feeling unwell 12/07/21 AM & PM:  Injection site pain, tiredness, joint pain & muscle pain 12/08/21 AM: injection site pain, tiredness, headache, muscle pain, chills, joint pain, nausea & feeling unwell
Approximately 14 hours after receiving the vaccine, I woke up at 2:15 a.m. feeling pains in my chest middle and extending through to my upper back.  The pain encompassed the span of my upper chest and back from one arm to the other.  I experienced very rapid heartbeats that I could feel throbbing from my head to my chest.  I was hesitant to move or rise from my bed because of the pain.  At 3:40 I called 911.  They did an EKG and I was told that my heart was fine.  My blood pressure was 180/90.  I chose not to go to the hospital but to call my doctor when his office opened up at 9:00 a.m. in approximately 5 hours.  My doctor had me come into his office.  I had another EKG which was fine and he sent me to have a Cat Scan. the same day which was also fine.  My doctor spoke to me and said that he felt that this was due to side effects of the vaccine.  I doubled up on my Acid Reflux medicine, taking 80 mg daily for  four days through Monday 2/22/2021.  I could not sleep well for three days after the vaccine experiencing pain in my chest and could not breathe deeply without feeling it.  Then I steadily improved and today I can take deep breaths with little pain.  I also experienced muscle pain in my left shoulder and neck but used Mineral Ice on my neck and was relieved in one day.
pain in middle finger and shoulder of left arm starting on day 6 after injection, which is now very mild (day 10). Red spot and moderate itching starting day 8 after injection.
having a rash all over her body; This is a spontaneous report from a contactable physician (patient). A 37-year-old female patient received the second dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Lot number: Unknown), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant at the time of vaccination. Historical vaccine includes first dose of bnt162b2 on an unspecified date for COVID-19 immunization. The patient experienced having a rash all over her body on 20Jan2021. The outcome of the event was unknown.   Information on lot and batch number has been requested.
7 days after vaccines fever 100-101. Mouth and throat red and swollen per mom. C/o pain knees and ankles. Red rash on legs on 8-6-17. Developed cough.
Patient became pale/grayish in color with onset of becoming unconscious within 30 seconds after the shot.  His skin stayed warm and dry.  He aroused on his own with a big gasping breathe within 10 seconds.  His Blood Pressure went to 62/42 with heart rate of 38 but it came up to 112/52 heart rate 48.  He complained about numbness and heaviness of face.  EMS was called because heart rate stayed 38-53.  EMS examine him in the ambulance and released him at 9:32 pm.  He came back to pharmacy at 9:35 and said everything was ok; "my heart rate and blood pressure has stabilized and I feel like myself"
Approx one hour after receiving vaccine, eyes swelled, eyeballs became red/watery, nose became congested to the point could not breathe through nose, and weird feeling on roof of mouth when swallowing. Symptoms were relived by taking 10ml of Benadryl. Swelling of eye area resolved completely by next morning.
Soldier complains of itching face and arms. Cheeks flushed. No rash noted on face, arms or torso. No respiratory symptoms. Soldier states she feels slightly light headed. B/P 134/88, Pulse 104, Resp. 20. Innoculated @ 10:00 AM. Dr. contacted - Recommended transport to nearest urgent care. Cpt to transport ASAP.
I contracted COVID-19 on 02/16/2022 with symptoms of chest tightness/pain, shortness of breathe, difficulty breathing, sore throat, cough, congestion, fatigue, loss of taste and smell, and I believed I had a case of bronchitis at the time. On 02/19/2022 I contacted my Cardiologists office who referred me to go to the Emergency Room. I went to the Emergency Room where I tested positive for COVID-19, also was diagnosed with COVID-19 Pneumonia via X-ray, and was prescribed 10 days of antibiotics, with a 3 day steroid pack. I was ill for 10 days, and contracted bronchitis 2 weeks after I had recovered from COVID-19. My sense of taste returned after 2 weeks, but I am still experiencing lingering fatigue and a scratchy throat/hoarseness.
pain in lower back; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain in lower back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (pain in lower back). At the time of the report, BACK PAIN (pain in lower back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Reporter did not allow further contact
Information has been received from a Licensed Vocational Nurse (L.V.N.) referring to a patient of unknown age and gender. History medication and drug allergies were not reported. On 19-MAY-2015 the patient was vaccinated with a dose of incorrect stored RECOMBIVAX HB (dose, strength and route were not reported) (lot# K017721, expire date 27-AUG-2016). Concomitant drug was not reported. At the time of reporting, no adverse effects were reported and it was reported if the patient sought any medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
Unable to wake up, was confused of surroundings.  Took two or three minutes to get "my wits" about me.  Fatigued and eyes feel heavy.  Joint stiffness mostly in knees.
Injection site swelled to size of a grapefruit.  It was warm to touch, hard, and tender.  Muscle in arm sore and shoulder area sore.  Incident reported to physician.  If swelling did not lessen he wanted me to be seen but improvement by follow in day although still swollen.
His arm turned red in about a four inch circle. It was also hot and very uncomfortable. I gave her Tylenol and Benadryl. Influenza Vaccine: Sanofi Fluzone 2013-2014 5ml Multidose Lot# UH907AB Left deltoid.
Fuzzy, leukocytosis, severe anemia, requiring hospitalization with RBC transfusion. Rotavirus, Pedvax, HIB and Prevnar given on 4/26/07 or 4/28/07 pm pts symptomatic with leukocytosis, anemia, thrombocytosis which gradually increased and pt finally hosp on 5/3/07.  06/04/2007 MR recieved for 4 day hospitalization 5/3-7/2007 for c/o vomiting x 3 days, watery diarrhea and decreased po intake. Seen in Ped. MD office where infant appeared weak and lethargic and a CBC revealed severe anemia.  Admitted for eval. and tx.  Required several days of IV fluids due to poor po intake and continued watery stools.  PE: c/w dehydration.  D/C DX:  Rotavirus Gastroenteritis.  Dehydration.  Anemia-improved.
Severe headache with mild fever, body aches and chills, nausea, severe fatigue. Began about 4 hours after injection and continued through the night.  Feeling mostly better the next day with ongoing fatigue and slight headache.  By second day all symptoms resolved.
Covid-19 Positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 Positive) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced COVID-19 (Covid-19 Positive). At the time of the report, COVID-19 (Covid-19 Positive) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, COVID-19: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were provided. No Treatment History was provided.
patient experienced swollen, red, hot upper arm at side of injection, patient took benadryl to relieve the symptoms; symptoms were dissipating after a couple of days
continuing redness, pruritic, painful lump at injection site (left arm) and worsening cough Recommended patient to take Tylenol or ibuprofen, and Benadryl as directed
Vomit; Lethargy; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VOMITING (non-serious) with onset 14Apr2021, outcome "unknown", described as "Vomit"; LETHARGY (non-serious) with onset 14Apr2021, outcome "unknown", described as "Lethargy"; CHILLS (non-serious) with onset 14Apr2021, outcome "unknown", described as "Chills". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
left swollen hand, exhaustion, edema of both legs, 3 pounds weight gain, eye floaters, confusion, exhaustion, widespread myalgiia and joint issues
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 18-JAN-2017, the patient received an improperly stored dose of M-M-R II (therapy type: recombinant human albumin, RHA) injection (lot # M015931 with expiration date at 30-MAR-2018; dose, route of administration and anatomical location were not reported). The administered dose of vaccine was exposed to a temperature of -14.4 degrees Celsius (C) for 54 minutes. Digital data logger was used to track the temperature. There was no previous temperature excursion reported. No adverse effects were reported. There was no product quality complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information is not expected as all scheduled correspondence was received. Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113.